Perrigo Company plc PRGO
Set alert
At close · Oct 30
After hours · Oct 30, 4:01 PM ET
- YTD
- +13.36%
- 1 year
- -23.55%
- Open
- 16.07
- Prev close
- 15.90
- Mkt cap
- 2.19B
- Vol
- 3.35M
- Avg vol
- 2.71M
- EPS
- -12.28
- P/E
- 0.00
- Div yield
- 7.30%
More statistics
- Low
- 15.42
- High
- 16.14
- Forward P/E
- 6.61
- Beta
- 0.69
- Short ratio
- 8.12
- Inst. own
- 115.75%
- Dividend
- 1.16
- Ex-div date
- Aug 27, 2026
- Earnings
- Nov 4, 2026
- 50-d avg
- 14.78
- 200-d avg
- 12.44
- 1y target
- 16.50
News
-
1 day ago benzinga.com
Canaccord Genuity Maintains Buy on Perrigo, Raises Price Target to $19
Canaccord Genuity analyst Susan Anderson maintains Perrigo (NYSE:PRGO) with a Buy and raises the price target from $17 to $19.
3 days ago prnewswire.com
Perrigo Announces Quarterly Dividend
DUBLIN, Oct. 29, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that its Board of Directors has approved a quarterly…
-
3 days ago benzinga.com
Perrigo To Sell Infant Formula Business To MeridianMade For Up To $175M; Co To Refocus On Consumer Self-Care Products
Advances Streamline pillar of Perrigo's Three-S plan through portfolio simplificationFurthers Perrigo's evolution into a simpler, more focused consumer self-care companyExpected to enhance Perrigo's
3 days ago prnewswire.com
Perrigo Announces Agreement to Divest Infant Formula Business to MeridianMade
Advances Streamline pillar of Perrigo's Three-S plan through portfolio simplification Furthers Perrigo's evolution into a simpler, more focused consumer self-care company Expected to enhance…
4 days ago zacks.com
Earnings Preview: Perrigo (PRGO) Q3 Earnings Expected to Decline
Perrigo (PRGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
1 week ago benzinga.com
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
Analysts highlight high-yield healthcare stocks Perrigo (7.09%), Pfizer (5.65%) and CVS Health (2.82%), with updated ratings and news.
1 week ago prnewswire.com
Perrigo to Release Third Quarter 2026 Financial Results on November 4, 2026
DUBLIN, Oct. 21, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that it plans to release its third quarter 2026 financial…
3 weeks ago gurufocus.com
Perrigo Co PLC (PRGO) Stock Up 3.9% and Still Undervalued -- GF Score: 60/100
On October 09, 2026, Perrigo Co PLC (PRGO) shares rose by 3.9%, bringing the current price to $15.06. This movement is notable within the context of its 52-week
1 month ago zacks.com
Perrigo (PRGO) Moves 6.1% Higher: Will This Strength Last?
Perrigo (PRGO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the…
1 month ago defenseworld.net
Squarepoint Ops LLC Cuts Position in Perrigo Company plc $PRGO
Squarepoint Ops LLC reduced its stake in shares of Perrigo Company plc (NYSE: PRGO) by 95.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and…
1 month ago zacks.com
Perrigo (PRGO) Up 13.8% Since Last Earnings Report: Can It Continue?
Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock?
2 months ago prnewswire.com
Perrigo to Attend the Barclays Global Consumer Conference
DUBLIN, Aug. 27, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that Interim President and CEO Albert Manzone and CFO…
2 months ago zacks.com
PRGO or NEOG: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Products stocks have likely encountered both Perrigo (PRGO) and Neogen (NEOG). But which of these two stocks is more attractive to value investors?
2 months ago zacks.com
Should Value Investors Buy Perrigo (PRGO) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the…
2 months ago benzinga.com
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Benzinga readers can review the latest analyst takes on high-yielding stocks in health care sector. Top analysts & recent news on PRGO, PFE, BMY.
2 months ago seekingalpha.com
My Top 5 Dividend Picks For August
I present my August top 5 dividend picks: PRGO, MZTI, NEE, TROW, and VICI, all rated Buy or Strong Buy for rising income and appreciation. Each pick trades at a significant discount to fair value…
2 months ago seekingalpha.com
Perrigo: The Rebound Is Just Getting Started
Perrigo Company remains substantially undervalued, with a Buy rating justified by strong income and growth potential. Recent quarterly EPS and revenue beats, coupled with market share gains, signal…
2 months ago zacks.com
PRGO vs. NEOG: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both Perrigo (PRGO) and Neogen (NEOG). But which of these two companies is the best option for those looking for…
2 months ago zacks.com
Are Investors Undervaluing Perrigo (PRGO) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the…
2 months ago marketbeat.com
Perrigo Q2 Earnings Call Highlights
Perrigo NYSE: PRGO reported second-quarter 2026 results that exceeded its internal earnings expectations, while sales declined amid soft consumer self-care categories, retailer inventory reductions…
2 months ago zacks.com
Perrigo Stock Rises 23% as Q2 Earnings & Sales Beat Estimates
PRGO tops Q2 EPS estimates as Infant Formula sales jump, helping offset softer demand and divestiture impacts while the company reaffirms 2026 guidance.
2 months ago seekingalpha.com
Perrigo Company plc (PRGO) Q2 2026 Earnings Call Transcript
Perrigo Company plc (PRGO) Q2 2026 Earnings Call Transcript
2 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Zhengye Biotechnology (NASDAQ:ZYBT) stock increased by 107.0% to $2.65 during Wednesday's regular session. The company's market cap stands at $60.6 million. Bluejay Diagnostics (NASDAQ:BJDX)…
2 months ago zacks.com
Perrigo (PRGO) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for Perrigo (PRGO) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street…
2 months ago benzinga.com
Wynn Resorts Posts Upbeat Q2 Earnings, Joins Bloomin' Brands, Shopify, Owens Corning And Other Big Stocks Moving Higher On Wednesday
US stocks rise, Wynn Resorts beat earnings expectations, share price jumps 10.9%. Other companies recording gains in today's session.
2 months ago zacks.com
Perrigo (PRGO) Surpasses Q2 Earnings and Revenue Estimates
Perrigo (PRGO) came out with quarterly earnings of $0.5 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.57 per share a year ago.
-
2 months ago benzinga.com
Perrigo Affirms FY2026 Adj EPS Guidance of $2.25-$2.55 vs $2.11 Est; Affirms FY2026 Sales Guidance of $4.019B-$4.189B vs $4.056B Est
Perrigo (NYSE:PRGO) affirms FY2026 Adj EPS guidance from $2.25-$2.55 to $2.25-$2.55 vs $2.11 analyst estimate. Affirms FY2026 sales outlook from $4.019 billion-$4.189 billion to $4.019 billion-$4.189…
-
2 months ago benzinga.com
Perrigo Q2 Adj. EPS $0.50 Beats $0.34 Estimate, Sales $1.023B Beat $1.013B Estimate
Perrigo (NYSE:PRGO) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $0.34 by 47.06 percent. This is a 12.28 percent decrease over earnings of $0.57 per…
4 months ago benzinga.com
Cramer Says Credo Technology Is 'Just So Good' — But Warns This Healthcare Name Is A 'Value Trap'
Jim Cramer recommends buying Constellation Energy (CEG) as it has come down too far. ManpowerGroup (MAN) is not a great win. Credo Technology (CRDO) is good. Cramer doesn't want Perrigo (PRGO).…
4 months ago benzinga.com
Mission Produce Posts Downbeat Q2 Earnings, Joins Ideaya Biosciences, Perrigo And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures higher, Nasdaq up 200 points. Mission Produce (NASDAQ: AVO) shares down on weak earnings. Other stocks also down in pre-market.
-
4 months ago benzinga.com
Perrigo Appoints Albert A. Manzone Interim President, CEO, Effective Immediately, Succeeding Patrick Lockwood-Taylor; Reaffirms FY26 Guidance
Perrigo Company plc (NYSE:PRGO) ("Perrigo" or the "Company"), a leading provider of Consumer Self-Care Products, today announced that its Board of Directors has appointed Albert A. Manzone, a member…
5 months ago benzinga.com
Perrigo Reports Q1 2026 Results: Full Earnings Call Transcript
Perrigo Reports Q1 2026 Results: Full Earnings Call Transcript
-
5 months ago benzinga.com
Perrigo Affirms FY2026 Adj EPS Guidance of $2.25-$2.55 vs $2.11 Est; Affirms FY2026 Sales Guidance of $4.019B-$4.189B vs $4.114B Est
Perrigo (NYSE:PRGO) affirms FY2026 Adj EPS guidance from $2.25-$2.55 to $2.25-$2.55 vs $2.11 analyst estimate. Affirms FY2026 sales outlook from $4.019 billion-$4.189 billion to $4.019 billion-$4.189…
-
5 months ago benzinga.com
Perrigo Q1 Adj. EPS $0.43 Beats $0.31 Estimate, Sales $939.000M Miss $1.031B Estimate
Perrigo (NYSE:PRGO) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $0.31 by 38.71 percent. This is a 28.33 percent decrease over earnings of $0.60 per…
-
6 months ago benzinga.com
FDA Takes Step Forward on Testosterone Therapy for Men
https://www.fda.gov/news-events/press-announcements/fda-takes-step-forward-testosterone-therapy-men
7 months ago benzinga.com
8 Stocks to Buy as Merger-Mania Takes Over
Consolidation wave creates opportunities for patient investors. 8 sectors leading now are health, semiconductors, medical devices, and media.
8 months ago benzinga.com
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields
Investors turn to dividend-yielding stocks during market turbulence. Benzinga offers latest analyst ratings and news on high-yielding stocks in the health care sector, including PRGO and PFE.
-
8 months ago benzinga.com
Canaccord Genuity Maintains Buy on Perrigo, Lowers Price Target to $17
Canaccord Genuity analyst Susan Anderson maintains Perrigo (NYSE:PRGO) with a Buy and lowers the price target from $20 to $17.
8 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session
-
8 months ago benzinga.com
Perrigo Sees FY2026 Adj EPS $2.25-$2.55 vs $2.65 Est; Sees Sales $4.019B-$4.189B vs $4.171B Est
Perrigo (NYSE:PRGO) is looking for FY2026 Adj EPS of $2.25-$2.55 vs $2.65 analyst estimate. sees sales of $4.019 billion-$4.189 billion vs $4.171 billion analyst estimate.
8 months ago benzinga.com
Perrigo Q4 Earnings Summary & Key Takeaways
Perrigo Q4 Earnings Summary & Key Takeaways
-
8 months ago benzinga.com
Perrigo Q4 Adj. EPS $0.77 Misses $0.79 Estimate, Sales $1.138B Beat $1.102B Estimate
Perrigo (NYSE:PRGO) reported quarterly earnings of $0.77 per share which missed the analyst consensus estimate of $0.79 by 3.02 percent. This is a 17.2 percent decrease over earnings of $0.93 per…
-
8 months ago benzinga.com
Earnings Scheduled For February 26, 2026
Earnings Scheduled For February 26, 2026
-
11 months ago benzinga.com
Primoris Services, Casella Waste Systems, Indivior, Hawaiian Electric, LKQ, Solstice Advanced Materials, Mohawk Industries, Under Armour, Power Integrations, Perrigo, Iridium Communications, Marriott Vacations Worldwide And Insperity Added To S&P SmallCap 600
https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20251205-1480992/1480992_december2025rebalance.pdf
-
11 months ago benzinga.com
UL Solutions, Pinterest, Booz Allen Hamilton, SPX Technologies, Dycom Industries, Borgwarner And Hecla Mining Co Set To S&P MidCap 400 December 22, 2025; Comfort Systems USA, Under Armour, Power Integrations, Perrigo, Iridium Communications, Marriott Vacations Worldwide And Insperity Exit S&P MidCap 400
https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20251205-1480992/1480992_december2025rebalance.pdf
11 months ago benzinga.com
Top 3 Health Care Stocks That May Rocket Higher In December
Top 3 Health Care Stocks That May Rocket Higher In December
-
12 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 months ago benzinga.com
Earnings Scheduled For November 5, 2025
Earnings Scheduled For November 5, 2025